Approximately five to ten percent of cancers are thought to be caused by mutations in genes that are associated with hereditary cancer syndromes.1
Genetic mutations have been associated with more than 50 hereditary cancer syndromes.1
Patients with genetic mutations associated with a hereditary cancer syndrome are at a higher risk of developing certain types of cancer than the general population, and usually at earlier age of onset than is typical.
Genetic testing can help determine whether a patient with a suspected personal or family history of cancer has an inherited gene mutation.
Genetic testing can also help identify family members at risk for developing cancers associated with a hereditary cancer syndrome.VistaSeq® hereditary cancer panels are multi-gene tests that detect inherited mutations in genes which have been associated with an increased risk of developing hereditary cancers.
VistaSeq® hereditary cancer panels are multi-gene tests that detect inherited mutations in genes which have been associated with an increased risk of developing hereditary cancers.
BRCAssure: Patients with BRCA mutations are at increased risk for breast, ovarian, and other cancers. Knowing your patient’s BRCA mutation status may assist in development of tailored prevention and treatment strategies. For this reason, Integrated Genetics offers a suite of BRCAssure tests to meet patients’ varied needs.
Mutation-specific sequencing: For family testing when a mutation has been specifically identified through one of our VistaSeq panels.
In addition to hereditary cancer screening, we also offer: serum screening and noninvasive prenatal testing (NIPT, sometimes called NIPS or cell-free DNA), including the pioneering whole-genome NIPT; carrier screening, from comprehensive to single-gene; and diagnostic testing that can be used on prenatal and products of conception (POC) samples, as well as pediatric, cord blood or adult samples.